FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956226410> ?p ?o ?g. }

• W2956226410 endingPage "837.e1" @default.
• W2956226410 startingPage "830" @default.
• W2956226410 abstract "Background & AimsLynch syndrome is the most common inherited cause of gastrointestinal cancer and increases risk for a variety of malignancies, including gastric cancer. We aimed to identify clinical factors associated with gastric cancer in carriers of germline variants causing Lynch syndrome.MethodsWe collected data from 52,758 consecutive individuals tested for genetic variants associated with Lynch syndrome from June 2006 through July 2013 at a commercial laboratory. We obtained clinical and demographic data, as well as information on personal and family histories of cancer (first- and second-degree relatives) from forms completed by ordering providers. We performed multivariate logistic regression to identify clinical factors associated with gastric cancer in carriers of mutations that cause Lynch syndrome (pathogenic mutations).ResultsAfter we excluded individuals with missing clinical data (n = 1664) or with multiple pathogenic mutations (n = 8), we analyzed data from 51,086 individuals. Of these, 3828 persons carried pathogenic mutations (1346 with mutations in MLH1, 1639 with mutations in MSH2, 670 with mutations in MSH6, 145 with mutations in PMS2, and 28 with mutations in EPCAM). Of the 3828 carriers of pathogenic mutations, 41 (1.1%) had a previous gastric cancer and 350 (9.1%) had 1 or more first- or second-degree relatives with gastric cancer. In multivariate analysis, male sex (odds ratio [OR], 2.82; 95% CI, 1.48–5.38), older age (OR, 2.07 per 10 years; 95% CI, 1.64–2.61), mutations in MLH1 (OR, 6.53; 95% CI, 1.50–28.42) or MSH2 (OR, 5.23 compared to mutations in MSH6, PMS2, or EPCAM; 95% CI, 1.21–22.71), and number of first-degree relatives with gastric cancer (OR, 2.52; 95% CI, 1.42–4.45), but not second-degree relatives (OR, 1.12; 95% CI, 0.40–3.18) were independently associated with gastric cancer among carriers of pathogenic mutations.ConclusionsIn an analysis of data from almost 4000 carriers of Lynch syndrome-associated mutations, we found history of gastric cancer to be independently associated with male sex, older age, mutations in MLH1 or MSH2, and number of first-degree relatives with gastric cancer. These findings suggest that personalized, risk-stratified approaches to gastric cancer surveillance may be appropriate for individuals with Lynch syndrome-associated mutations. Lynch syndrome is the most common inherited cause of gastrointestinal cancer and increases risk for a variety of malignancies, including gastric cancer. We aimed to identify clinical factors associated with gastric cancer in carriers of germline variants causing Lynch syndrome. We collected data from 52,758 consecutive individuals tested for genetic variants associated with Lynch syndrome from June 2006 through July 2013 at a commercial laboratory. We obtained clinical and demographic data, as well as information on personal and family histories of cancer (first- and second-degree relatives) from forms completed by ordering providers. We performed multivariate logistic regression to identify clinical factors associated with gastric cancer in carriers of mutations that cause Lynch syndrome (pathogenic mutations). After we excluded individuals with missing clinical data (n = 1664) or with multiple pathogenic mutations (n = 8), we analyzed data from 51,086 individuals. Of these, 3828 persons carried pathogenic mutations (1346 with mutations in MLH1, 1639 with mutations in MSH2, 670 with mutations in MSH6, 145 with mutations in PMS2, and 28 with mutations in EPCAM). Of the 3828 carriers of pathogenic mutations, 41 (1.1%) had a previous gastric cancer and 350 (9.1%) had 1 or more first- or second-degree relatives with gastric cancer. In multivariate analysis, male sex (odds ratio [OR], 2.82; 95% CI, 1.48–5.38), older age (OR, 2.07 per 10 years; 95% CI, 1.64–2.61), mutations in MLH1 (OR, 6.53; 95% CI, 1.50–28.42) or MSH2 (OR, 5.23 compared to mutations in MSH6, PMS2, or EPCAM; 95% CI, 1.21–22.71), and number of first-degree relatives with gastric cancer (OR, 2.52; 95% CI, 1.42–4.45), but not second-degree relatives (OR, 1.12; 95% CI, 0.40–3.18) were independently associated with gastric cancer among carriers of pathogenic mutations. In an analysis of data from almost 4000 carriers of Lynch syndrome-associated mutations, we found history of gastric cancer to be independently associated with male sex, older age, mutations in MLH1 or MSH2, and number of first-degree relatives with gastric cancer. These findings suggest that personalized, risk-stratified approaches to gastric cancer surveillance may be appropriate for individuals with Lynch syndrome-associated mutations." @default.
• W2956226410 created "2019-07-23" @default.
• W2956226410 creator A5005140127 @default.
• W2956226410 creator A5009517468 @default.
• W2956226410 creator A5034561048 @default.
• W2956226410 creator A5048337523 @default.
• W2956226410 creator A5050977500 @default.
• W2956226410 creator A5076089607 @default.
• W2956226410 creator A5079620607 @default.
• W2956226410 creator A5082845071 @default.
• W2956226410 date "2020-04-01" @default.
• W2956226410 modified "2023-10-18" @default.
• W2956226410 title "Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome" @default.
• W2956226410 cites W1966498049 @default.
• W2956226410 cites W1980178943 @default.
• W2956226410 cites W2035624229 @default.
• W2956226410 cites W2042885655 @default.
• W2956226410 cites W2095725724 @default.
• W2956226410 cites W2106832044 @default.
• W2956226410 cites W2114229573 @default.
• W2956226410 cites W2129567712 @default.
• W2956226410 cites W2136615861 @default.
• W2956226410 cites W2149903711 @default.
• W2956226410 cites W2156115771 @default.
• W2956226410 cites W2156299764 @default.
• W2956226410 cites W2157304020 @default.
• W2956226410 cites W2159899668 @default.
• W2956226410 cites W2162077547 @default.
• W2956226410 cites W2165606389 @default.
• W2956226410 cites W2257698165 @default.
• W2956226410 cites W2545241042 @default.
• W2956226410 cites W2613184396 @default.
• W2956226410 cites W2616335683 @default.
• W2956226410 cites W2766596777 @default.
• W2956226410 cites W2774422690 @default.
• W2956226410 cites W2802548205 @default.
• W2956226410 cites W2883644433 @default.
• W2956226410 cites W2889473065 @default.
• W2956226410 cites W2895900449 @default.
• W2956226410 doi "https://doi.org/10.1016/j.cgh.2019.07.012" @default.
• W2956226410 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6960373" @default.
• W2956226410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31319185" @default.
• W2956226410 hasPublicationYear "2020" @default.
• W2956226410 type Work @default.
• W2956226410 sameAs 2956226410 @default.
• W2956226410 citedByCount "31" @default.
• W2956226410 countsByYear W29562264102020 @default.
• W2956226410 countsByYear W29562264102021 @default.
• W2956226410 countsByYear W29562264102022 @default.
• W2956226410 countsByYear W29562264102023 @default.
• W2956226410 crossrefType "journal-article" @default.
• W2956226410 hasAuthorship W2956226410A5005140127 @default.
• W2956226410 hasAuthorship W2956226410A5009517468 @default.
• W2956226410 hasAuthorship W2956226410A5034561048 @default.
• W2956226410 hasAuthorship W2956226410A5048337523 @default.
• W2956226410 hasAuthorship W2956226410A5050977500 @default.
• W2956226410 hasAuthorship W2956226410A5076089607 @default.
• W2956226410 hasAuthorship W2956226410A5079620607 @default.
• W2956226410 hasAuthorship W2956226410A5082845071 @default.
• W2956226410 hasBestOaLocation W29562264101 @default.
• W2956226410 hasConcept C104317684 @default.
• W2956226410 hasConcept C111425858 @default.
• W2956226410 hasConcept C121608353 @default.
• W2956226410 hasConcept C126322002 @default.
• W2956226410 hasConcept C13514818 @default.
• W2956226410 hasConcept C143998085 @default.
• W2956226410 hasConcept C156957248 @default.
• W2956226410 hasConcept C2776559941 @default.
• W2956226410 hasConcept C2776674815 @default.
• W2956226410 hasConcept C2778677574 @default.
• W2956226410 hasConcept C2779115348 @default.
• W2956226410 hasConcept C501734568 @default.
• W2956226410 hasConcept C526805850 @default.
• W2956226410 hasConcept C54355233 @default.
• W2956226410 hasConcept C60748783 @default.
• W2956226410 hasConcept C71924100 @default.
• W2956226410 hasConcept C86803240 @default.
• W2956226410 hasConceptScore W2956226410C104317684 @default.
• W2956226410 hasConceptScore W2956226410C111425858 @default.
• W2956226410 hasConceptScore W2956226410C121608353 @default.
• W2956226410 hasConceptScore W2956226410C126322002 @default.
• W2956226410 hasConceptScore W2956226410C13514818 @default.
• W2956226410 hasConceptScore W2956226410C143998085 @default.
• W2956226410 hasConceptScore W2956226410C156957248 @default.
• W2956226410 hasConceptScore W2956226410C2776559941 @default.
• W2956226410 hasConceptScore W2956226410C2776674815 @default.
• W2956226410 hasConceptScore W2956226410C2778677574 @default.
• W2956226410 hasConceptScore W2956226410C2779115348 @default.
• W2956226410 hasConceptScore W2956226410C501734568 @default.
• W2956226410 hasConceptScore W2956226410C526805850 @default.
• W2956226410 hasConceptScore W2956226410C54355233 @default.
• W2956226410 hasConceptScore W2956226410C60748783 @default.
• W2956226410 hasConceptScore W2956226410C71924100 @default.
• W2956226410 hasConceptScore W2956226410C86803240 @default.
• W2956226410 hasFunder F4320332161 @default.
• W2956226410 hasFunder F4320337351 @default.
• W2956226410 hasIssue "4" @default.
• W2956226410 hasLocation W29562264101 @default.

• next